Articles tagged with:

View all tags

Innovation

Australian innovation pilot aims to reduce cost of vaccination in developing world

GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.

Environment

Trusted partnership achieves supply chain improvements

When we received feedback that the number of eskies used for distribution of our vaccines was excessive we worked with our partner Symbion to find a solution.

Access to healthcare

The fight against malaria

For the past 30 years, GSK scientists have been working with other organisations across the globe with the aim to develop what could be the world’s first malaria vaccine.

How we do business

Crowd sourcing new treatments for malaria

New medicines are urgently needed for diseases of the developing world and those medicines need to be affordable.

Innovation

Innovation and collaboration with Monash University

Our Community

NYSF - inspiring the next generation of scientists

With much of the world’s future innovation to come from science, technology, engineering and maths (STEM), it is very important that the innovators of tomorrow are supported and mentored.

How we do business

Harnessing the electrical language of the body to treat disease

Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.

Innovation

Bioelectronics

GSK's Bioelectronics R&D unit is pursuing a relatively new scientific field that could one day result in a new class of medicines that would not be pills or injections but miniaturised, implantable devices.

How we do business

Open source: the future of medical discovery

There is growing recognition that no single research body or group has the know-how or resources to tackle the most widespread and persistent diseases. Fortunately, a growing number of scientists are engaged in open source innovation that removes barriers and creates a more transparent environment for medical discovery.

How we do business

PharmAus 2017: Showcasing the health and economic benefits of innovation in medicines

The inaugural PharmAus showcase saw GSK and 19 other innovative pharmaceutical companies illustrate our industry’s investment and collaboration with Australia’s top research institutes, universities, biotechs and patients, to deliver the latest breakthroughs in treatment.

Our Community

A comic book on vaccines

Immunisation rates among Australian children has risen significantly over the years. However, there remains a distinct disparity between children from Aboriginal and Torres Strait Islander communities and other Australians.

Our people

Philip Leslie

Philip Leslie leads innovation at GSK's manufacturing site in Boronia. He was recognised at the 2017 Victorian Manufacturing Awards as a Hall of Fame honoree.

Back to top